Results 161 to 170 of about 2,212 (184)
Some of the next articles are maybe not open access.
Real-life experience with rilonacept for the treatment of recurrent pericarditis
European Heart JournalAbstract Background Rilonacept, a soluble Interleukin-1 (IL-1) receptor fusion protein that neutralizes IL-1α and IL-1β, has shown efficacy in symptom resolution, weaning of standard-of-care therapies, and reducing the frequency of recurrent pericarditis (RP) episodes in clinical trials.
G Thomas +3 more
openaire +1 more source
Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis
Annals of Pharmacotherapy, 2022Nicholas C Schwier
exaly
Use of rilonacept in patients with recurrent pericarditis during COVID-19 disease
Expert Opinion on Biological Therapy, 2022Lucia, Trotta +9 more
openaire +2 more sources
The IL-1 Trap Rilonacept Resolves and Prevents Recurrent Pericarditis
Nature Reviews Cardiology, 2021Irene Fernández-Ruiz
exaly
Rilonacept for familial Mediterranean fever?
Nature Reviews Rheumatology, 2012openaire +1 more source
Rilonacept (Arcalyst) for recurrent pericarditis.
The Medical letter on drugs and therapeutics, 2021openaire +1 more source

